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Coronary arteriogenesis is a central step in cardiogenesis, requiring coordinated generation
and integration of endothelial cell and vascular smooth muscle cells. At present, it is unclear
whether the cell fate programme of cardiac progenitors to generate complex muscular or
vascular structures is entirely cell autonomous. Here we demonstrate the intrinsic ability of
vascular progenitors to develop and self-organize into cardiac tissues by clonally isolating and
expanding second heart ﬁeld cardiovascular progenitors using WNT3A and endothelin-1
(EDN1) human recombinant proteins. Progenitor clones undergo long-term expansion and
differentiate primarily into endothelial and smooth muscle cell lineages in vitro, and contribute
extensively to coronary-like vessels in vivo, forming a functional human–mouse
chimeric circulatory system. Our study identiﬁes EDN1 as a key factor towards the
generation and clonal derivation of ISL1þ vascular intermediates, and demonstrates
the intrinsic cell-autonomous nature of these progenitors to differentiate and self-organize
into functional vasculatures in vivo.
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T
he heart is one of the ﬁrst organs to be formed in the
embryo, and its function is critical for the circulation of
nutrients and the removal of waste products to ensure
proper development of the embryo subsequently. The formation
of the mammalian heart is a complex process, involving two
distinct groups of mesodermal progenitor cells, the ﬁrst and
second heart ﬁelds (FHF and SHF, respectively). While the
FHF primarily gives rise to the left ventricle and parts of atria,
the SHF develops into the right ventricle, outﬂow tract (OFT) and
parts of atria1–3. Both FHF and SHF cardiac progenitors, marked
by HCN4 and ISL1, respectively, have since been isolated and
characterized4–7.
Unlike pluripotent stem cells (embryonic or induced pluripo-
tent stem cells), where culture systems have been well-studied and
deﬁned culture conditions have been robustly established8–10,
only a few adult progenitor stem cell populations such as
the haematopoietic stem cells, pancreatic progenitors and
bone-marrow-derived human mesenchymal stem cells (hMSCs)
are able to propagate long-term in deﬁned conditions11–13. Other
studies reporting the expansion of committed endocrine
progenitors, and endoderm progenitors derived from embryonic
stem cells (ESCs) or induced pluriportent stem cells also require
the co-culture with organ-matched mesenchyme or mouse
embryonic ﬁbroblasts (MEFs), respectively14,15. At present,
ISL1þ SHF cardiovascular progenitors (CVPs) can only be
expanded and kept multipotent on WNT3A-over-expressing
feeders16. Owing to a lack of robust, deﬁned long-term culture
conditions that is capable of maintaining clonally expanded,
multipotent ISL1þ CVP over prolong periods, we sought to
identify novel factors that can support the long-term propagation
of ISL1þ CVPs in vitro.
To achieve this, we differentiated human ESCs with ISL1þ
reporter into CVPs, and adopted a comparative bioinformatics
approach to identify candidate signalling pathways that may be
active in uncommitted ISL1þ CVPs. This was achieved by
performing microarray analysis on subregions of the fetal heart,
followed by pairing the paracrine factors present in speciﬁc
regions, with corresponding receptors that are highly expressed in
uncommitted CVPs. The rationale of this approach is that during
early cardiogenesis, it is the surrounding mesenchyme that
secretes factors to either maintain the proliferation of progenitor
cells or provide signals to direct their differentiation. Therefore,
examination of paracrine factors that are speciﬁc and highly
expressed in both OFT and right ventricle would be useful for
clonal expansion of ISL1þ CVPs that were previously shown to
be speciﬁcally present in these two regions of the heart. In our
study, we identiﬁed new factors that support CVP expansion and
maintenance, as well as major pathways previously reported to be
important through knockout mice models, indicating that our
approach was successful. Testing our top candidate endothelin-1
(EDN1), we demonstrated that the factor supports clonal
expansion of self-organizing human ISL1þ CVPs in a deﬁned
culture condition.
Results
Growth factor-receptor pairs enriched in the SHF progenitors.
To begin addressing the self-assembly ability of CVPs, we ﬁrst
demonstrated clonal derivation of SHF multipotent progenitors.
Taking a genomic approach, we identiﬁed EDN1 as a potential
growth factor that maintains clonal expansion of CVPs in a
chemically deﬁned, serum-free medium. Using previously curated
list of growth factors and growth factor receptors expressed in
humans8, and applying the criteria of signal intensity Z20 from
the Illumina array data (background signal subtracted),
several hundreds of growth factors expressed in different
regions (two atria, two ventricles and OFT) of 11-week-old
human embryonic fetal hearts were identiﬁed (Supplementary
Data 1–5). Similarly, a database for membrane receptors
expressed in multipotent ISL1þ CVPs was obtained through
ﬂorescence-activated cell sorting of differentiated human ESCs at
day 7 using an established protocol4 (Supplementary Fig. 1a).
This was achieved using an ISL1-Cre knock-in human ESC
line (H9G1) previously generated in our laboratory4.
ISL1þ CVPs were isolated by sorting for ISL1þ /CD24 /
Pan-Neuronal population, thus eliminating subsets of ISL1þ
cells belonging to the pancreatic islet and neuronal lineages17,18
(Supplementary Fig. 1b).
To identify receptors in CVPs that may be involved in their
maintenance, we further imposed stricter criteria of signal
intensity Z50 and day 7 ISL1þ cells/day 14 ISL1þ -derived
endothelial cell ratio Z1.2 to select for receptors that are
signiﬁcantly downregulated when multipotent cardiac
progenitors differentiate. A total of 57 membrane receptors
were identiﬁed (Supplementary Data 6). Further analysis
using interaction data from Biomolecular Interaction Network
Database (BIND) and Human Protein Reference Database
(HPRD) to examine useful ligand–receptor interactions utilized
by ISL1þ CVPs to maintain multipotency revealed 11 interaction
growth factor-growth factor receptor pairs (GF-GFR), involving
eight growth factors that are highly expressed in both OFT and
right ventricle of the human fetal heart (Supplementary Data 7
and Supplementary Fig. 1c). Not surprisingly, all the identiﬁed
growth factors have been previously shown to manifest
cardiovascular-related phenotypes in knockout mouse models
(Supplementary Data 7). From our analysis, EDN1 emerged as
the top candidate that can potentially maintain and expand CVP.
Endothelin-1 supports multipotency of SHF CVP. To validate
our microarray data, we examined the expression of EDN1 in
week 11 human fetal heart by immunocytochemistry, which
revealed high expression of the growth factor in both OFT and
right ventricle, regions derived from the SHF ISL1þ CVPs.
Comparatively, much lower expression of the growth factor was
observed in the left ventricle (Fig. 1a). Examination of the
corresponding EDN1 receptors (EDNRA and EDNRB) in ISL1þ
CVPs further suggested the utility of the EDN1 growth
factor-receptor axis in the maintenance of CVPs multipotency
(Fig. 1b), where the relative quantiﬁcation of expressions of both
receptors (EDNRA and EDNRB) is provided in Supplementary
Fig. 1d. It is also noteworthy that human ESCs also express
both EDN1 receptors (Supplementary Fig. 1e), albeit at a much
lower level. Several studies have previously demonstrated that
Notch signalling negatively regulates cardiac differentiation
in vivo although the mechanism of its action remains largely
unknown19,20. Consistently, we found that EDN1 activates Notch
signalling effector gene targets such as HEY1, HEY2, HEYL and
HES1 in a dose-dependent manner (Supplementary Fig. 2a–c).
Next, we evaluated the utility of EDN1 in driving human ESC
(ISL1 reporter cell line, H9G1) differentiation into SHF CVPs in a
deﬁned medium containing WNT3A, EDN1 or both. WNT3A
was used as a comparison in our study, as multipotent ISL1þ
CVPs were previously reported to be maintained and expanded
on WNT3A over-expressing feeder cells16. Intriguingly, based on
green ﬂuorescent protein (GFP) expression, EDN1 was found to
be inefﬁcient in driving human ESC differentiation towards
ISL1-expressing cells in the embryoid body assay although it was
our top candidate ligand obtained from microarray analysis
(Fig. 1c). More interestingly, the number of ISL1þ -expressing
cells (GFPþ ) was markedly reduced when both WNT3A and
EDN1 were used in combination. However, through ﬂow
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Figure 1 | Endothelin-1 supports clonal isolation of ISL1þ CVP. (a) Immunoﬂuorescence on week 11 human fetal heart shows strong expression of EDN1
(stained red) at both OFT and right ventricle (RV). Enlarged images (indicated by yellow boxes) show small clusters of ISL1þ CVPs in the walls of OFT.
n¼ 3 experiments. Scale bars, 100 mm. (b) Immunocytochemistry demonstrating high expressions of EDNRA and EDNRB receptors (stained red) for EDN1
in ISL1þ CVPs. EDNRA and EDNRB staining in siRNA-treated ISL1þ CVPs serves as negative control. Cell nuclei (blue) were stained with 4,6-diamindino-
2-phenylindole (DAPI). Scale bar, 50mm. (c) Differentiation of human ESCs (H9G1) towards ISL1-expressing cells (GFPþ) in embryoid bodies (EBs) when
cultured in basal medium (BM) supplemented with 100ngml 1 EDN1, 100 ngml 1 WNT3A or both. Low numbers of GFPþ cells were observed in various
EB sizes (1.5 105, 3.0 105 and 4.5 105 cells) cultured in the presence of EDN1. Scale bars, 0.5mm. (d) Flow cytometric analysis of ISL1þ cells in EBs.
Human ESCs differentiated in media containing EDN1 showed high percentages (Z70%) of cells, which were negative for both CD24 and Pan-Neuronal
surface antigens. Error bars indicate s.d., n¼ 3 experiments. **Po0.001, evaluated by Student’s t-test. (e) Graphical representation of colony-forming
efﬁciency of the ISL1þ CVPs in BM supplemented with WNT3A, EDN1 or both. Single-progenitor cells were seeded on MEF feeders at various cell densities
(10,000, 20,000 and 30,000 cells) per well in six-well plates. Colonies were visible after day 7 and were subsequently stained with crystal violet for
quantitation. Error bars indicate s.d., n¼ 3 experiments. *P¼0.05 and **Po0.03, evaluated by Student’s t-test. (f) Immunocytochemistry illustrating the
expression of ISL1 in H9G1-derived CVP clones. The expression of ISL1 gene (red) was revealed as a nuclear protein. ISLþ CVP colony was stained negative
for OCT4, a pluripotency marker, indicating that the colony did not arise from undifferentiated human ESCs. In addition, ISL1þ CVP colony was stained
negative for HCN4, a recently reported FHF marker. Cell nuclei (blue) were stained with DAPI. Scale bar, 100mm. (g) ISL1þ CVP clone transfected with
siRNAs targeting EDN1, EDNRA or EDNRB showedBZ60% decrease in the number of ISL1þ/CD24/Pan-Neuronal cells compared with control RNAi,
where a non-targeting siRNA was transfected. The CVP cells were transfected on alternate days with a ﬁnal concentration of 60 nM of respective siRNAs.
Cells were collected for ﬂow cytometric analysis on day 10. Bars, s.d.; n¼ 3 experiments. *P¼0.0002 and **P¼0.0001, evaluated by Student’s t-test.
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cytometric analysis, we determined that although fewer GFPþ
cells were present in EDN1-containing medium, B70–80% of
the GFPþ cells were ISL1þ /CD24 /Pan-Neuronal (Fig. 1d).
The overall number of ISL1þ CVPs generated in each condition
however, remained relatively similar, suggesting that EDN1
restricts ISL1 expression in cardiac mesoderm.
The multipotent ISL1þ CVPs can be clonally derived and
expanded from human ESCs. Using a combination of EDN1
and WNT3A ligands16, single ISL1þ CVPs were sorted and
expanded clonally, with a clonal efﬁciency of 1–2% (Fig. 1e and
Supplementary Fig. 2d). In this study, ISL1þ CVP clones
were successfully isolated and expanded from two human ESC
ISL1 reporter lines, H9 and HUES3 (Supplementary Fig. 3),
respectively. Immunostaining of the progenitor colonies
demonstrated that they were positive for the SHF marker ISL1,
but negative for the pluripotency marker OCT4, as well as the
recently reported FHF marker, HCN4 (ref. 7; Fig. 1f).
To further validate the utility of EDN1 in clonal expansion of
the multipotent CVPs, we adopted the RNA interference (RNAi)
strategy to study the loss-of-function effects on these progenitors.
EDN1 signalling was perturbed by two methods: siRNAs
targeting EDN1 to remove the endogenous growth factor and
siRNAs targeting EDNRA and EDNRB to deplete the
receptors that bind to EDN1. Analyses of the effects of RNAi
on the maintenance of ISL1þ CVPs were performed by sorting
for ISL1þ /CD24 /Pan-Neuronal population. As expected, the
percentage of cells that were ISL1þ /CD24 /Pan-Neuronal
were markedly reduced to o40% following EDN1, EDNRA or
EDNRB RNAi treatment (Fig. 1g). Concomitantly, there was a
decrease in the number of colonies formed once EDN1 axis was
perturbed indicating that EDN1 maintains the ISL1þ cells in the
progenitor cell state (Supplementary Fig. 4a). Quantitative PCR
results conﬁrmed that signiﬁcant downregulation of EDN1,
EDNRA and EDNRB transcripts (4 50%) was achieved by the
respective siRNAs (Supplementary Fig. 4b–d). Together, these
results clearly indicate the importance of EDN1 in the
maintenance of ISL1þ CVPs, through autocrine and paracrine
signalling. Consistently, Edn-1 (also known as ET1) and Ednra
knockout mice have been reported to exhibit cardiovascular
malformations involving the SHF derivatives21–23. The mutant
mice are characterized by interrupted aortic arch, tubular
hypoplasia of the aortic arch, aberrant right subclavian artery
and ventricular septal defect with abnormalities of the OFT.
Long-term clonal expansion of multipotent SHF CVP. To
determine the expansion capacity of a single ISL1þ CVP cell, we
explored the possibility of maintaining a continuous culture of
ISL1þ CVP clones in deﬁned media supplemented with EDN1,
WNT3A or a combination of both for several passages (Fig. 2a).
WNT3A over-expressing feeder was previously reported to
support the expansion of ISL1þ SHF progenitors16. In the
current study, long-term expansion of the cardiac progenitors in
deﬁned conditions revealed that cells cultured in the presence of
WNT3A alone showed an initial increase in cell numbers (before
P2), which declined thereafter, suggesting that WNT3A alone
provides a signal for a short-term expansion of the CVPs, but not
for their long-term maintenance. Once the progenitor cell
differentiates, it becomes less proliferative resulting in a decline
in cell number. In contrast, progenitors cultured in medium
supplemented with only EDN1 illustrated an B7,000-fold
increase in cell number over a period of ﬁve passages, while
progenitors cultured in medium containing both EDN1 and
WNT3A showed an increase of B28,000-fold in cell number
during the same period (Fig. 2a), suggesting a synergistic effect
between WNT3A and EDN1. The proliferative effect of EDN1
was illustrated through an increase in phosphorylated AKT levels
in CVPs, with a ﬁvefold increase in phosphorylated AKT/total
AKT ratio as compared with control (Fig. 2b,c). The cell state
of these ISL1þ CVPs was validated with quantitative PCR, which
showed high expression of key cardiac mesodermal markers such
as ISL1, MESP1, GATA4, MEF2C and T-BRACHYURY (Fig. 2d).
It is noteworthy that at present, the expanded clones have been
maintained in feeder-free conditions using a chemically deﬁned
medium for over 30 passages without losing their CVP identity.
Taken together, these results point towards the role of EDN1 in
maintaining the multipotency of CVPs, while WNT3A primarily
functions to enhance its proliferative capability.
ISL1þ CVP differentiates into cardiac derivatives in vitro.
Thus far, we have identiﬁed EDN1 as a potent factor to clonally
expand SHF ISL1þ CVPs. Because this progenitor pool
holds great clinical potential, we wanted to investigate if it also
possesses the hallmark of a multipotent progenitor, that is, the
ability to differentiate into different distinct cardiac lineages.
We assessed two ISL1þ CVP clones in generating cardiac
lineages such as cardiomyocytes, endothelial cells and smooth
muscle cells in vitro in accordance to published protocols24,25.
Differentiation of CVPs to endothelial cells was ﬁrst observed on
day 3 and typically gave rise to 5–15% endothelial cells by day 7
(Fig. 3a,b), while speciﬁcation towards cardiomyocytes (20–30%)
and smooth muscle cells (50–70%) took 1–2 weeks. Contraction
of clonally derived cardiomyocytes typically occurs 3–4 weeks
after differentiation (Supplementary Movie 1). Identities of the
differentiated cell types obtained from ISL1þ CVP clones were
further conﬁrmed by immunocytochemistry. Representative
staining for endothelial cells, smooth muscle cells and
cardiomyocytes were demonstrated by the presence of CD31,
smooth myosin heavy chain (SMMHC) and cardiac troponin
T (CTNT), respectively (Fig. 3a). Quantitative PCR of markers
speciﬁc for the various cardiac lineages (endothelial cell:
CD31 and VWF; smooth muscle cell: SM22 and SMMHC;
cardiomyocyte: NKX2.5, GATA4, MEF2C, TBX5, CX43
and TNNT2) further validated the expression of these
genes (Fig. 3c–e).
ISL1þ CVP primarily generate vasculature in vivo. The
establishment of self-organizing organoids in ex vivo culture has
become a new paradigm to evaluate differentiation potential of
tissue-speciﬁc stem cells. Being a committed CVP, we envisage
the CVPs to differentiate and self-organize into tissue organoids
in cultures, similar to recent studies demonstrating formation of
organoids obtained from kidney26,27, optic cup28, intestine29,
stomach30, liver31, cerebral cortex32 and pancreas11,33. However,
attempts to generate three-dimensional cardiac structures in vitro
proved to be futile, possibly due to a lack of mesenchymal
interactions or extracellular matrix reported to be important
for tissue organogenesis and regeneration34–36. To circumvent
this limitation, we injected CVPs (2 106 cells) into the heart
after induction of myocardial infarction, as well as the kidney
capsules of NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NOD/SCID)
mice to assess for long-term engraftment, differentiation and
self-assembly capabilities of CVPs in vivo.
Evidently, engraftment of the injected cells was achieved since
GFP-labelled cells were present in both the kidney capsule and
in the myocardium 3 weeks post transplantation (Fig. 4a).
Haematoxylin and eosin, as well as Masson staining revealed that
the xenograft in the kidney capsule comprised largely of pericytes,
which belongs to the same cell lineage as vascular smooth muscle
cells37–40, and connective tissues with numerous perforating
functional blood vessels carrying blood cells (Fig. 4b). Similarly,
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formation of numerous GFP-labelled blood vessels that are
anastomosed to host circulatory system (carrying blood cells) was
also observed at the site of myocardial infarction, where the
CVPs were transplanted (Fig. 4b and Supplementary Fig. 5).
Interestingly, while the CVPs gave rise to all three cardiac lineages
(endothelial cell, cardiomyocyte and smooth muscle cell) in vitro
on various differentiation stimuli, our transplantation results
revealed that only early passages of CVPs (opassage 10) can give
rise to cardiomyocytes, in addition to endothelial and smooth
muscle cells in vivo (Supplementary Fig. 6). It was observed that
CVPs of later passages (4passage 20) almost exclusively
contribute to vasculogenic lineages regardless of the sites of
transplantation as evident by CD31, SMMHC and a-smooth
muscle actin (a-SMA) staining (Fig. 4c,e). While the effects of
continuous passaging on restricting lineage potential of the CVPs
remained elusive, such restriction on differentiation potentials
have been previously reported in other studies involving long-
term expansion of human mesenchymal stem cells41,42 and
human fetal neural stem cells43. Consistently, earlier studies have
demonstrated that depletion of Edn-1 (ET1) in knockout mouse
models resulted in severe cardiovascular malformations mainly
involving vasculature formation in the developing heart21–23.
Close examination of the blood vessels formed revealed rings of
a-SMA-positive cells surrounding the endothelial cells,
resembling those of coronary arteries (Fig. 4c). Larger arteries
(diameter Z15 mm) were also present, albeit at a much lower
frequency (Fig. 4d). These large arteries were found to possess an
inner layer of CD31-positive cells that was surrounded by a thick
layer of cells, which were stained positive for SMMHC, a-SMA
and FBN1 (Fig. 4e). Through Masson staining, a ring of
connective tissue and matrix was also found to be present
throughout the thick wall of the larger coronary-like arteries
(diameter Z60mm). A summary of the various types of blood
vessels, based on their diameter sizes, and the frequency of their
occurrence in xenografts are tabulated in Fig. 4d (injection into
the myocardium) and Supplementary Fig. 7a (injection into the
kidney capsule). Collectively, these results suggest that the CVPs
possess the intrinsic ability to differentiate and self-organize into
blood vessels in vivo, a feat not achievable by simply injecting a
mixture of endothelial and smooth muscle cells into the kidney
capsule or myocardium.
The propensities of these transplanted cells to form teratomas
in vivo were also assessed through long-term transplantation
assay. As expected, large teratomas were formed from kidney
capsule injected with human ESCs (H9G1) after 10 weeks
(Supplementary Fig. 7b). On the contrary, H9G1-derived CVPs
injected into the kidney capsule were devoid of endoderm- and
ectoderm-derived tissues, and only contained mesoderm-derived
structures (Supplementary Fig. 7c).
Discussion
The heart is an essential muscular organ that serves the primary
role of maintaining the circulatory system in our body. Thus, the
proper development and proliferation of the cardiac progenitors
are critical requirements to ensure subsequent survival of
embryos. The spontaneous formation of blood vessels in the
xenografts resembles early stages of cardiogenesis during which
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key cardiac structures are quickly formed to ensure the proper
development of a functional heart for the supply of nutrients and
oxygen, as well as the removal of waste materials from the
developing embryo, respectively.
While several recent studies have reported the derivation of
coronary artery endothelial cells and the smooth muscle cells
from the endocardium44 and epicardium45, respectively, we do
not exclude the possibilities that vasculature formation could arise
from cells originating from other regions of the heart. Lineage
tracing experiments have shown that the ISL1þ CVPs give rise
primarily to the OFT and the right ventricle6. As such, it is
unlikely that the SHF ISL1þ CVP plays a signiﬁcant role in
vasculature formation in the endocardial wall particularly during
rapid expansion of the compact myocardium. Instead, we
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Figure 3 | In vitro differentiation of ISL1þ CVP clones into cardiomyocytes, as well as endothelial and smooth muscle cells. Undifferentiated ISL1þ CVP
clones were maintained in medium supplemented with EDN1 and WNT3A. Differentiation of the CVPs into various cardiac lineages was achieved using
protocols described under material and method. (a) Immunocytochemistry demonstrating the presence of endothelial cell (EC; CD31þ ), smooth muscle
cell (SM; SMMHCþ ) and cardiomyocyte (CM; CTNTþ ) on differentiation with various differentiation media. EC was stained with mouse anti-CD31
primary antibody while SM and CM were stained with mouse anti-SMMHC and mouse anti-CTNT, respectively, at 1:100 dilutions. Cell nuclei (blue) were
stained with 4,6-diamindino-2-phenylindole (DAPI). Scale bar, 100mm. (b) Graphical representation illustrating differentiation efﬁciencies of ISL1þ CVP
into various cardiac lineages. Flow cytometric analyses for EC (CD31þ ), SM (SMMHCþ ) and CM (CTNTþ ) differentiation were performed on two
progenitor clones (clones 1 and 2). Bars, s.d. of n¼ 3 experiments. *Po0.05 and **Po0.001, evaluated by Student’s t-test. (c–e) Quantitative PCR
conﬁrming the expression of CD31 and VWF (EC markers); SM22 and SMMHC (SM markers); and NKX2.5, GATA4, MEF2C, TBX5, CX43 and TNNT2 (CM
markers) when ISL1þ CVP clones were differentiated into the various cardiac lineages. Gene expressions were normalized to the respective
undifferentiated ISL1þ CVP clones. n¼ 3 experiments. *Po0.05 and **Po0.01, evaluated by Student’s t-test.
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Figure 4 | ISL1þ CVP differentiates and forms human–mouse chimeric circulatory system in vivo. (a) Xenografts stained positive for GFP present in
kidney capsule and adult mouse heart after myocardial infarction (MI), demonstrating the engraftment of ISL1þ CVP-derived cells 3 weeks post
transplantation. Cell nuclei (blue) were stained with 4,6-diamindino-2-phenylindole (DAPI). Scale bar, 100mm. (b) Representative images of xenograft
showing engraftment of ISL1þ CVP-derived differentiated cells in the kidney capsule and myocardium. Vasculature network could be seen from the surface of
the xenograft (kidney capsule), with numerous blood vessels carrying red blood cells (RBCs) as shown in the haematoxylin and eosin (H&E) and Masson
stains (indicated with black arrows). Site of MI is marked by red arrow (lower panel). Connective tissues revealed by Masson stain (stained blue) were
observed throughout the xenograft. Enlarged images show functional blood vessels carrying blood cells. RV, right ventricle; LV, left ventricle. Scale bar, 100mm.
(c) Representative immunoﬂuorescent image of muscularized blood vessels in xenografts (both kidney capsule and myocardium). Rings of endothelial cells
were stained positive for CD31 (stained red). The arteries were surrounded by additional ring of smooth muscle cells that were stained positive for a-SMA.
Cell nuclei (blue) were stained with DAPI. Scale bar, 50mm. (d) Graphical representation of the numbers and sizes of blood vessels observed in the xenograft
per ﬁeld (transplantation into myocardium after MI). Results were tabulated from 10 random ﬁelds of H&E stains of the xenografts. Bars, s.d. of n¼ 3 sections.
D, diameter. *Po0.05 and **Po0.001, evaluated by Student’s t-test. (e) Large coronary-like artery developed from the transplanted ISL1þ CVP in the kidney
capsule. Immunoﬂuorescent staining of the section revealed an inner layer of endothelial cells (stained positive for CD31), which is surrounded by a thick layer
of smooth muscle cells that were stained positive for both SMMHC and a-SMA. Connective tissue surrounding the artery was further depicted by the
presence of ﬁbrillin-1 (FBN1) as well as Masson stain (blue). Cell nuclei (blue) were stained with DAPI. Scale bar, 100mm. Scale bar in enlarged image, 50mm.
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hypothesize that the in vivo generation of de novo vasculature
after cell injection resembles the early stages of heart
development, in particular the formation of the proximal end
of the coronary artery.
Evidently, this suggests that a single CVP cell possesses the
ability to self-renew, differentiate into other cardiac lineages and
self-assemble into functional cardiac-like tissues. Although
examination of long-term transplanted xenografts revealed a
lack of atrial- or ventricular-like structures, the xenografts
were mostly packed with vasculatures that were supported by
stromal elements and connective tissues such as collagen,
ﬁbronectin, elastin and so on. Occasionally, large arteries
with thick layer of smooth muscle cells surrounding a thin inner
ring of endothelial cells were found in the xenograft. The
frequencies of these differentially sized arteries and capillaries
present in the xenografts reﬂect an organized angiogenesis
process, signifying the formation of a hierarchical vascular
network in a developing organ46,47.
In summary, our study identiﬁes EDN1 as a key component,
acting through both autocrine and paracrine means to maintain
and expand clonal ISL1þ CVPs. These cultured CVPs were
eventually shown to differentiate primarily into endothelial and
smooth muscle cell lineages, forming a functional human–mouse
chimeric circulatory system in vivo (summarized in Fig. 5).
The isolation, culture and expansion of ISL1þ CVP clones
demonstrates the intrinsic autonomous nature of this progenitor
cell to differentiate and self-organize into functional vasculatures.
The ability to generate blood vessels from CVPs henceforth
presents the potential to model developmental diseases or
degenerative conditions involving the heart and circulatory
system by introducing disease mutations using CRISPR
technology48. Moving forward, culturing CVPs in deﬁned
conditions thus opens avenues for the development of
regenerative therapeutics and tissue engineering approaches
to generate vascularized cardiac patches or blood vessels for
cell-based therapies49.
Methods
Cell culture of H9G1 human ES and H9G1-ISL1þ SHF CVPs. The human ESC
line (H9G1) and HUES3 ISL1-RFP reporter cell lines, previously generated in our
laboratory4, were cultured in feeder-free condition on Matrigel (BD, Franklin
Lakes, NJ). The cells were maintained in mTeSR1 medium (Stemcell Technologies).
For culture of ISL1þ CVPs, a basal medium (CGM) containing 35% complete
IMDM/65% DMEM–Ham F-12 mix containing 2% B27, 2% BSA Fraction V,
0.1mmol l 1 2-mercaptoethanol, 4 ngml 1 epidermal growth factor, 10 ngml 1
basic ﬁbroblast growth factor, 40 nmol l 1 cardiotrophin-1, 40 nmol l 1 thrombin,
1% Pen/Strep and 1% L-glutamine. Endothelin-1 and WNT3A were supplemented
fresh into the medium.
Gene knockdown using siRNA in H9G1-ISL1þ SHF progenitor. Silencer select
pre-designed siRNAs targeting human EDN1, EDNRA, EDNRA and control siRNA
(Ambion) were used for transfection into ISL1þ CVPs using Lipofectamine
RNAi MAX Transfection Reagent (Invitrogen), according to the manufacturer’s
recommendation. The siRNA sequences are provided in Supplementary Data 8.
Brieﬂy, 60 nM of siRNA was used for each transfection into 1.0 105 cells in
suspension, and subsequently plated onto a 12-well tissue culture plate. Repeated
transfection was performed with respective siRNAs every alternate day. The
cells were collected after 10 days of culture for ﬂow cytometric and quantitative
real-time PCR (qPCR) analysis.
Human ES differentiation and clonal isolation of ISL1þ CVP. The human ES
(H9G1) and HUES3 ISL1-RFP reporter cell lines were differentiated to embryoid
bodies as described by Bu et al.4 Brieﬂy, human ESCs were treated with collagenase
(1mgml 1; Gibco), and then suspended in differentiation medium containing
BMP4 (20 ngml 1), activin A (10 ngml 1) and WNT3A (100 ngml 1; all from
R&D Systems) before transferring to six-well ultra low cluster plates (Costar), and
cultured at 37 C. ISL1-expressing cells (GFP- or RFP-positive) were typically
observed on day 7 after differentiation. The embryoid bodies were dissociated with
accutase (Life Technologies). Single-cell suspension was obtained, and the cells
were stained with PE-conjugated mouse anti-CD24 (BD Bioscience) and mouse
anti-human Pan-Neuronal marker (Millipore) at concentration of 1:100 dilution,
followed by donkey anti-mouse IgG Alexa 647 at 1:1,000 dilution (Invitrogen).
Isolation of ISLþ CVP was achieved by ﬂuorescence-activated cell sorting for
GFPþ /CD24 /Pan-Neuronal or RFPþ /CD24 /Pan-Neuronal cells. Single-
sorted cells were seeded onto irradiated feeder layer (MEF) and cultured with CGM
medium supplemented with EDN1 and WNT3A.
RNA extraction and cRNA synthesis. For cultured cell samples, 2 106 cells
were collected and lysed in 800ml of TRIzol reagent (Invitrogen). The samples were
allowed to stand for 5min at room temperature, after which 160ml of chloroform
was added to allow for phase separation by centrifugation at 12,000g for 15min at
4 C. Following that, the aqueous phase was transferred to a fresh tube, and equal
volume of isopropanol was added and mixed. RNA samples were allowed to
precipitate at room temperature for another 10min. The precipitated RNA samples
were pelleted by centrifugation at 12,000g for 15min at 4 C. Five hundred
nanogram of total RNA from each sample were used to generate cRNA using the
Illumina Totalprep RNA Ampliﬁcation Kit (Ambion) according to the manu-
facturer’s recommendations. Brieﬂy, RNA samples were reverse transcribed to
synthesize ﬁrst strand cDNA by mixing 11 ml of RNA samples (500 ng) with 9 ml of
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Figure 5 | Schematic illustration of the importance of EDN1 in the maintenance of CVPs. We proposed that EDN1 promotes the clonal expansion of
CVPs. Given the appropriate stimuli, CVPs were able to differentiate towards all three cardiac lineages (cardiomyocyte, smooth muscle cell and endothelial
cell) in vitro (o10 passages) while almost exclusively contributed to vascular lineages in vivo (420 passages). This suggests that EDN1 primes the CVP
towards a vascular lineage while WNT3A functions primarily to enhance their proliferation.
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reverse transcription master mix and incubated at 42 C for 2 h. An additional 80 ml
of second strand master mix was added into the sample and incubated for 2 h at
16 C to generate the second strand cDNA. Puriﬁcation of cDNA was achieved by
adding 250 ml of cDNA-binding buffer to each sample. The mixture was passed
through a cDNA ﬁlter cartridge and washed with 500 ml of wash buffer. cDNA
was eluted with 20ml of 55 C nuclease-free water. In vitro transcription to
synthesize cRNA was achieved by adding 7.5 ml of IVT master mix to each cDNA
sample, and incubated for 14 h at 37 C. A volume of 75 ml of nuclease-free water
was added to each sample to stop the reaction. Puriﬁed cRNA samples were
subsequently obtained by adding 350 ml of cRNA-binding buffer to each sample,
followed by an additional 250 ml of 100% ethanol to precipitate the cRNA samples.
The mixture was passed through cRNA ﬁlter cartridge, and washed with 650 ml of
wash buffer. Puriﬁed cRNA samples were eventually eluted with 100 ml of 55 C
nuclease-free water.
Reverse transcription and qPCR. RNA samples (500 ng) were reverse transcribed
to obtain cDNA using the iScript cDNA Synthesis kit (Bio-Rad). Primer sequences
are provided in Supplementary Data 9. Quantitative PCR analyses were performed
using the ABI Viia7 Real Time PCR System. The threshold cycle (Ct) was
determined to be Z35. Each experiment was repeated at least twice. S.d.’s of the
means in qPCR experiments were obtained from three independent experiments.
Microarray analysis. Microarray study was conducted using HumanHT-12 v4
BeadChip (Illumina). The microarray data have been deposited in GEO under
accession code GSE75985. Hybridization and scanning of the BeadChip were
performed using the Illumina BeadArray Reader. All gene expression data
were ﬁrst subtracted from the background, and then normalized using the
cross-correlation.
Immunocytochemistry. Immunocytochemical analysis was performed using the
respective antibodies: mouse anti-human CD31 monoclonal antibody (AbD
Serotec; 1:100); mouse anti-ISL1 monoclonal antibody (Hybridoma Bank; 1:200);
mouse anti-CTNT polyclonal antibody (Thermo Scientiﬁc; 1:250); rabbit anti-
SMMHC polyclonal antibody (Biomedical Technologies; 1:200); and mouse
anti-human SMA monoclonal antibody (DAKO; 1:250). Cells were ﬁrst collected
and washed once with PBS. Fixation of cells was achieved with 4% paraf-
ormaldehyde for 30min, followed by treatment with 0.3% Triton X to permeabilize
cells, if necessary. The cells were then blocked with PBS containing 5% fetal bovine
serum and 1% BSA for 30min at room temperature. Primary antibodies were
added at recommended dilutions and incubated for 1 h at room temperature. After
washing, the cells were incubated for another 45min at room temperature without
light exposure with either 1:1,000 diluted Alexa Fluor 488 or Alexa Fluor 594
secondary antibodies. Nuclei were counterstained with 4,6-diamindino-2-pheny-
lindole. The cells were observed under a ﬂuorescent microscope (Nikon TS-100).
Western blot. CVPs were cultured in basal medium in the presence or absence of
endothelin-1 growth factor for 5 days. For the preparation of cell lysates, cell pellets
were incubated in RIPA lysis buffer (1% Nonidet P-40, 0.5% deoxycholate, 5M
NaCl and 1M Tris (pH 7.4)) for 10min at 4 C, and then centrifuged at 11,400g for
15min at 4 C. Quantiﬁcation of protein extract was carried out using the Protein
Assay (Bio-Rad) according to the manufacturer’s instructions. Electrophoretic
analysis was performed using 10–15% SDS–PAGE gel (Bio-Rad). Gels were blotted
onto nitrocellulose membrane (Amersham Biosciences), which were then probed
with rabbit anti-human AKT, anti Phospho-AKT (Ser473; Cell Signaling), mouse
anti b-actin (Santa Cruz), rabbit anti-human HEY1 and HEY2 (both from
GeneTex) and mouse anti a-tubulin (Santa Cruz) primary antibodies according to
the manufacturer’s instructions. Primary antibodies were detected with species-
speciﬁc horseradish peroxidase-conjugated secondary antibodies (Santa Cruz) and
ECL western blotting detection system (Amersham Biosciences).
Transplantation of ISL1þ CVPs into mouse kidney capsule. NOD.Cg-Prkdcscid
Il2rgtm1Wjl/SzJ (NOD/SCID) mouse strain harbouring a null mutation of the
common cytokine receptor g chain (Il2rgtm1Wjl) (NOD/SCID/IL2rgnull) from
Jackson Laboratory (Bar Harbor, ME) was used for cell transplantation. All
procedures were performed on male mice between 8 and 10 weeks of age. Brieﬂy,
mice were anaesthetized with 2.5% avertin, and 2 106 ISL1þ CVPs were injected
into the kidney capsule using an 18G tuohy epidural needle.
Myocardial infarction and lectin perfusion. All surgical and experimental
procedures with mice were done in accordance with European Community
Council Directives and approved by the Stockholm’s Norra Djurfo¨rso¨ketiska
Na¨mnd (Stockholm, Sweden). Myocardial infarction was induced in 8-week-old
male NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NOD/SCID) mouse strain by
permanent ligation of the left anterior descending, as previously described35.
Brieﬂy, the left thoracic region was shaved and sterilized. The animal was
intubated, and positive pressure ventilation was provided by a ventilator, where the
tidal volume and rate were determined by preprogrammed settings based on
animal weight. The heart was exposed through a left thoracotomy (transverse
incision was made between the fourth and ﬁfth intercostal spaces) and a suture
with a no. 4½ circle taper point needle was used to ligate the left anterior
descending coronary artery. The thoracotomy and skin were sutured closed in
layers, and the mouse was removed from ventilation when normal breathing was
established. The procedure was completed inB30min, after which the animal was
placed in a heated holding cages for recovery.
Lectin perfusion was performed at least 1 month after grafting according to
established protocol50. Brieﬂy, tomato lectin from Lycopersicon esculentum
(DL-1177, Vector laboratories) at a ﬁnal concentration of 1mgml 1 was injected
into the tail vein of anaesthetized mice. Lectin binds to the luminal surface of
endothelial cells of human and mice blood vessels. Mice were killed 5min later and
the hearts were collected and ﬁxed in 4% paraformaldehyde.
Histopathology and immunochemical staining. Mice were killed either 3 weeks
(short term) or 10 weeks (long term) post transplantation. Transplanted kidneys
were collected and ﬁxed in 4% paraformaldehyde. The tissues were processed with
Tissue Processor (Leica Microsystems, Buffalo Grove, IL) and embedded in
parafﬁn. Sections were cut at a 5-mm thickness, mounted on poly-lysine-coated
slides (Thermal Fisher Scientiﬁc, Pittsburgh, PA), de-waxed, rehydrated and
processed for haematoxylin and eosin an Masson staining according to standard
protocols. For immunoﬂuorescent staining, antigen retrieval was carried out using
citrate buffer (10mM citric acid, 0.05%, pH 6.0). Sections were then immersed for
1 h in blocking buffer from M.O.M basic kit (Vector Laboratories), then incubated
in primary antibody (made up in M.O.M diluent buffer) at 4 C overnight, followed
by incubation in secondary antibody at 37 C for 1 h. Rabbit anti-GFP polyclonal
antibody (Abcam), mouse anti-human CD31 monoclonal antibody (AbD serotec),
mouse anti-CTNT polyclonal antibody (Thermo Scientiﬁc), mouse anti-SMMHC
polyclonal antibody (Biomedical Technologies), rabbit anti-human FBN1
polyclonal antibody (Abcam) and rabbit anti-GFP polyclonal antibody (Abcam)
were used at 1:100 dilution. Secondary antibodies, donkey anti-rabbit or
anti-mouse with different Alexa Fluor conjugations were purchased from
Invitrogen and used at a 1:1,000 dilution. All sections were counterstained with
4,6-diamindino-2-phenylindole (blue). Sections were mounted with anti-fade
reagent (Vectashield) and then viewed under a ﬂuorescent microscope
(Nikon TS-100).
Statistics. qPCR values are expressed as mean±s.d. Results were tested for
statistical signiﬁcance using Student’s t-test, two sided based on assumed normal
distributions. P values o0.05 were considered statistically signiﬁcant.
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